Minimum tolerable interval of radioimmunotherapy and autologous stem cell transplantation after high-dose chemotherapy for relapsed or refractory aggressive B cell Non-Hodgkin-Lymphoma provides excellent disease control
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Article (Journal) Conference Paper |
| Language: | English |
| Published: |
2014
|
| In: |
Blood
Year: 2014, Volume: 124, Issue: 21 |
| ISSN: | 1528-0020 |
| Subjects: | |
| Online Access: | Verlag, kostenfrei, Volltext: http://www.bloodjournal.org/content/124/21/3986?sso-checked=true/
|
| Author Notes: | Justin Hasenkamp, Georg Hess, Bernd Hertenstein, Mathias Witzens-Harig, Lutz Uharek, Martin Gramatzki, Michael Pfreundschuh, Gerald Wulf, Lorenz H. Truemper, Norbert Schmitz, Bertram Glass |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1504769880 | ||
| 003 | DE-627 | ||
| 005 | 20230426120347.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 150702s2014 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)1504769880 | ||
| 035 | |a (DE-576)434769886 | ||
| 035 | |a (DE-599)BSZ434769886 | ||
| 035 | |a (OCoLC)1340697021 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 245 | 0 | 0 | |a Minimum tolerable interval of radioimmunotherapy and autologous stem cell transplantation after high-dose chemotherapy for relapsed or refractory aggressive B cell Non-Hodgkin-Lymphoma provides excellent disease control |c Justin Hasenkamp, Georg Hess, Bernd Hertenstein, Mathias Witzens-Harig, Lutz Uharek, Martin Gramatzki, Michael Pfreundschuh, Gerald Wulf, Lorenz H. Truemper, Norbert Schmitz, Bertram Glass |
| 264 | 1 | |c 2014 | |
| 300 | |a 1 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 02.07.2015 | ||
| 655 | 7 | |a Konferenzschrift |0 (DE-588)1071861417 |0 (DE-627)826484824 |0 (DE-576)433375485 |2 gnd-content | |
| 700 | 1 | |a Hasenkamp, Justin |d 1974- |0 (DE-588)129356077 |0 (DE-627)393982254 |0 (DE-576)297616870 |4 oth | |
| 700 | 1 | |a Witzens-Harig, Mathias |0 (DE-588)1050736516 |0 (DE-627)784812322 |0 (DE-576)404988970 |4 oth | |
| 773 | 0 | 8 | |i In |t Blood |d Washington, DC : American Society of Hematology, 1946 |g 124(2014,21) Artikel-Nr. 3986, 1 S. |h Online-Ressource |w (DE-627)266886647 |w (DE-600)1468538-3 |w (DE-576)075961938 |x 1528-0020 |7 nnas |a Minimum tolerable interval of radioimmunotherapy and autologous stem cell transplantation after high-dose chemotherapy for relapsed or refractory aggressive B cell Non-Hodgkin-Lymphoma provides excellent disease control |
| 773 | 1 | 8 | |g volume:124 |g year:2014 |g number:21 |g extent:1 |a Minimum tolerable interval of radioimmunotherapy and autologous stem cell transplantation after high-dose chemotherapy for relapsed or refractory aggressive B cell Non-Hodgkin-Lymphoma provides excellent disease control |
| 856 | 4 | 0 | |u http://www.bloodjournal.org/content/124/21/3986?sso-checked=true/ |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20150702 | ||
| 993 | |a ConferencePaper | ||
| 994 | |a 2014 | ||
| 998 | |g 1050736516 |a Witzens-Harig, Mathias |m 1050736516:Witzens-Harig, Mathias |d 910000 |d 910100 |e 910000PW1050736516 |e 910100PW1050736516 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 999 | |a KXP-PPN1504769880 |e 2847463291 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 02.07.2015"],"language":["eng"],"recId":"1504769880","person":[{"given":"Justin","family":"Hasenkamp","role":"oth","display":"Hasenkamp, Justin"},{"family":"Witzens-Harig","given":"Mathias","display":"Witzens-Harig, Mathias","role":"oth"}],"title":[{"title":"Minimum tolerable interval of radioimmunotherapy and autologous stem cell transplantation after high-dose chemotherapy for relapsed or refractory aggressive B cell Non-Hodgkin-Lymphoma provides excellent disease control","title_sort":"Minimum tolerable interval of radioimmunotherapy and autologous stem cell transplantation after high-dose chemotherapy for relapsed or refractory aggressive B cell Non-Hodgkin-Lymphoma provides excellent disease control"}],"physDesc":[{"extent":"1 S."}],"relHost":[{"origin":[{"dateIssuedKey":"1946","publisher":"American Society of Hematology ; Saunders ; HighWire Press","dateIssuedDisp":"1946-","publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif."}],"id":{"eki":["266886647"],"zdb":["1468538-3"],"issn":["1528-0020"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Blood","title":"Blood","subtitle":"journal of the American Society of Hematology"}],"pubHistory":["1.1946 -"],"titleAlt":[{"title":"Blood online"}],"part":{"volume":"124","text":"124(2014,21) Artikel-Nr. 3986, 1 S.","extent":"1","year":"2014","issue":"21"},"disp":"Minimum tolerable interval of radioimmunotherapy and autologous stem cell transplantation after high-dose chemotherapy for relapsed or refractory aggressive B cell Non-Hodgkin-Lymphoma provides excellent disease controlBlood","note":["Gesehen am 21.04.2023"],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"266886647","corporate":[{"display":"American Society of Hematology","roleDisplay":"Herausgebendes Organ","role":"isb"}],"language":["eng"]}],"name":{"displayForm":["Justin Hasenkamp, Georg Hess, Bernd Hertenstein, Mathias Witzens-Harig, Lutz Uharek, Martin Gramatzki, Michael Pfreundschuh, Gerald Wulf, Lorenz H. Truemper, Norbert Schmitz, Bertram Glass"]},"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"2014"}],"id":{"eki":["1504769880"]}} | ||
| SRT | |a MINIMUMTOL2014 | ||